Tumor-stroma interactions: Their role in the control of tumor cell invasion

Biochimie

Volumn 87, Issue 3-4 SPEC. ISS., 2005, Pages 321-328

  Zigrino, P ^a   Loffek S ^a   Mauch, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Proteases; Receptors; Stroma; Tumor

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VERY LATE ACTIVATION ANTIGEN 2;

ANGIOGENESIS; AUTOCRINE EFFECT; CANCER CONTROL; CANCER GROWTH; CANCER INVASION; CELL COMMUNICATION; CELL INTERACTION; CELL PROLIFERATION; ENZYME REGULATION; HUMAN; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA CELL; NONHUMAN; PANCREAS CARCINOMA; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN DOMAIN; REVIEW; SQUAMOUS CELL CARCINOMA; STROMA CELL; ULTRAVIOLET IRRADIATION;

EID: 15244348665     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.10.025     Document Type: Short Survey

References (95)

1. R.A. Cairns, R. Khokha, and R.P. Hill Molecular mechanisms of tumor invasion and metastasis: an integrated view Curr Mol Med 3 2003 659 671
2. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
3. A. Tang, M.S. Eller, M. Hara, M. Yaar, S. Hirohashi, and B.A. Gilchrest E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro J. Cell Sci. 107 1994 983 992
4. M. Hsu, T. Andl, G. Li, J.L. Meinkoth, and M. Herlyn Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression J. Cell Sci. 113 2000 1535 1542
5. D.S. Sanders, K. Blessing, G.A. Hassan, R. Bruton, J.R. Marsden, and J. Jankowski Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours Mol. Pathol. 52 1999 151 157
6. S. Islam, T.E. Carey, G.T. Wolf, M.J. Wheelock, and K.R. Johnson Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion J. Cell Biol. 135 1996 1643 1654
7. K. Tomita, A. Van:Bokhoven, G.J. Van:Leenders, E.T. Ruijter, C.F. Jansen, and M.J. Bussemakers Cadherin switching in human prostate cancer progression Cancer Res. 60 2000 3650 3654
8. J. Heino Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation Int. J. Cancer 65 1996 717 722
9. P. Keely, L. Parise, and R. Juliano Integrins and GTPases in tumour cell growth, motility and invasion Trends Cell Biol. 8 1998 101 106
10. E. Ruoslahti, and M.D. Pierschbacher New perspectives in cell adhesion: RGD and integrins Science 238 1987 491 497
11. M.J. Humphries, K. Olden, and K.M. Yamada A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells Science 233 1986 467 470
12. I. Saiki, J. Murata, J. Iida, T. Sakurai, N. Nishi, and K. Matsuno Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences Br. J. Cancer 60 1989 722 728
13. N. Reinmuth, W. Liu, S.A. Ahmad, F. Fan, O. Stoeltzing, and A.A. Parikh Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice Cancer Res. 63 2003 2079 2087
14. B. Felding-Habermann, E. Fransvea, T.E. O'Toole, L. Manzuk, B. Faha, and M. Hensler Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells Clin. Exp. Metastasis 19 2002 427 436
15. B. Felding-Habermann, B.M. Mueller, C.A. Romerdahl, and D.A. Cheresh Involvement of integrin alpha V gene expression in human melanoma tumorigenicity J. Clin. Invest. 89 1992 2018 2022
16. P.G. Natali, M.R. Nicotra, A. Bartolazzi, R. Cavaliere, and A. Bigotti Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression Int. J. Cancer 54 1993 68 72
17. C.E. Klein, D. Dressel, T. Steinmayer, C. Mauch, B. Eckes, and T. Krieg Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils J. Cell Biol. 115 1991 1427 1436
18. P. Kurschat, P. Zigrino, R. Nischt, K. Breitkopf, P. Steurer, and C.E. Klein Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines J. Biol. Chem. 274 1999 21056 21062
19. E.H. Danen, C. Marcinkiewicz, I.M. Cornelissen, A.A. Van:Kraats, J.A. Pachter, and D.J. Ruiter The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells Exp. Cell Res. 238 1998 188 196
20. R. Mortarini, A. Gismondi, A. Maggioni, A. Santoni, M. Herlyn, and A. Anichini Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins Cancer Res. 55 1995 4702 4710
21. I. Rabinovitz, R.B. Nagle, and A.E. Cress Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo Clin. Exp. Metastasis 13 1995 481 491
22. A. Richmond, and H.G. Thomas Purification of melanoma growth stimulatory activity J. Cell. Physiol. 129 1986 375 384
23. B. Farrow, and B.M. Evers Inflammation and the development of pancreatic cancer Surg. Oncol. 10 2002 153 169
24. A.E. Postlethwaite, J. Keski-Oja, H.L. Moses, and A.H. Kang Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta J. Exp. Med. 165 1987 251 256
25. M.S. Steiner, and E.R. Barrack Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro Mol. Endocrinol. 6 1992 15 25
26. N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, and S. Shappell TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 2004 848 851
27. J. Massague, S.W. Blain, and R.S. Lo TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
28. M. Herlyn, C. Berking, G. Li, and K. Satyamoorthy Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation Melanoma Res. 10 2000 303 312
29. A. Bagnato, L. Rosano, F. Spinella, V. Di:Castro, R. Tecce, and P.G. Natali Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression Cancer Res. 64 2004 1436 1443
30. F. Meier, U. Caroli, K. Satyamoorthy, B. Schittek, J. Bauer, and C. Berking Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma Exp. Dermatol. 12 2003 296 306
31. C. Berking, R. Takemoto, K. Satyamoorthy, R. Elenitsas, and M. Herlyn Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin Am. J. Pathol. 158 2001 943 953
32. E. Voronov, D.S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, and Y. Iwakura IL-1 is required for tumor invasiveness and angiogenesis Proc. Natl. Acad. Sci. USA 100 2003 2645 2650
33. Z. Werb, T.H. Vu, J.L. Rinkenberger, and L.M. Coussens Matrix-degrading proteases and angiogenesis during development and tumor formation APMIS 107 1999 11 18
34. L.M. Coussens, and Z. Werb Matrix metalloproteinases and the development of cancer Chem. Biol. 3 1996 895 904
35. P. Basset, J.P. Bellocq, C. Wolf, I. Stoll, P. Hutin, and J.M. Limacher A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas Nature 348 1990 699 704
36. P. Baumann, P. Zigrino, C. Mauch, D. Breitkreutz, and R. Nischt Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes Br. J. Cancer 83 2000 1387 1393
37. P. Kurschat, C. Wickenhauser, W. Groth, T. Krieg, and C. Mauch Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography J. Pathol. 197 2002 179 187
38. M. Takahashi, S. Fukami, N. Iwata, K. Inoue, S. Itohara, and H. Itoh In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture Pharmacol. Res. 46 2002 155 163
39. K. Airola, N. Johansson, A.L. Kariniemi, V.M. Kahari, and U.K. Saarialho-Kere Human collagenase-3 is expressed in malignant squamous epithelium of the skin J. Invest. Dermatol. 109 1997 225 231
40. U.B. Hofmann, J.R. Westphal, A.J. Zendman, J.C. Becker, D.J. Ruiter, and G.N. Van:Muijen Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression J. Pathol. 191 2000 245 256
41. A. Okada, J.P. Bellocq, N. Rouyer, M.P. Chenard, M.C. Rio, and P. Chambon Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas Proc. Natl. Acad. Sci. USA 92 1995 2730 2734
42. N. Koshikawa, G. Giannelli, V. Cirulli, K. Miyazaki, and V. Quaranta Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 J. Cell Biol. 148 2000 615 624
43. J. Lohi Laminin-5 in the progression of carcinomas Int. J. Cancer 94 2001 763 767
44. M. Patarroyo, K. Tryggvason, and I. Virtanen Laminin isoforms in tumor invasion, angiogenesis and metastasis Semin. Cancer Biol. 12 2002 197 207
45. R.E. Seftor, E.A. Seftor, N. Koshikawa, P.S. Meltzer, L.M. Gardner, and M. Bilban Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma Cancer Res. 61 2001 6322 6327
46. E. Wandel, A. Grasshoff, M. Mittag, U.F. Haustein, and A. Saalbach Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro Exp. Dermatol. 9 2000 34 41
47. H. Kataoka, R. DeCastro, S. Zucker, and C. Biswas Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase Cancer Res. 53 1993 3154 3158
48. S. Menashi, M. Serova, L. Ma, S. Vignot, S. Mourah, and F. Calvo Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells Cancer Res. 63 2003 7575 7580
49. S. Zucker, M. Hymowitz, E.E. Rollo, R. Mann, C.E. Conner, and J. Cao Tumorigenic potential of extracellular matrix metalloproteinase inducer Am. J. Pathol. 158 2001 1921 1928
50. L.C. Bordador, X. Li, B. Toole, B. Chen, J. Regezi, and L. Zardi Expression of EMMPRIN by oral squamous cell carcinoma Int. J. Cancer 85 2000 347 352
51. T. Kanekura, X. Chen, and T. Kanzaki Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts Int. J. Cancer 99 2002 520 528
52. H. Guo, R. Li, S. Zucker, and B.P. Toole EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface Cancer Res. 60 2000 888 891
53. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. Von Schalscha, R.T. Aimes, and W.G. Stetler-Stevenson Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85 1996 683 693
54. E.I. Deryugina, B. Ratnikov, E. Monosov, T.I. Postnova, R. DiScipio, and J.W. Smith MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells Exp. Cell Res. 263 2001 209 223
55. V. Noe, B. Fingleton, K. Jacobs, H.C. Crawford, S. Vermeulen, and W. Steelant Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 J. Cell Sci. 114 2001 111 118
56. A. Lochter, S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells J. Cell Biol. 139 1997 1861 1872
57. M. Kajita, Y. Itoh, T. Chiba, H. Mori, A. Okada, and H. Kinoh Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration J. Cell Biol. 153 2001 893 904
58. H. Nakamura, N. Suenaga, K. Taniwaki, H. Matsuki, K. Yonezawa, and M. Fujii Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase Cancer Res. 64 2004 876 882
59. P. Mignatti, and D.B. Rifkin Plasminogen activators and matrix metalloproteinases in angiogenesis Enzyme Protein 49 1996 117 137
60. T.C. Wun Plasminogen activation: biochemistry, physiology, and therapeutics Crit. Rev. Biotechnol. 8 1988 131 148
61. R.L. Shapiro, J.G. Duquette, D.F. Roses, I. Nunes, M.N. Harris, and H. Kamino Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals Cancer Res. 56 1996 3597 3604
62. E.M. Spiers, G.S. Lazarus, and B. Lyons-Giordano Expression of plasminogen activators in basal cell carcinoma J. Pathol. 178 1996 290 296
63. T. Yasuda, Y. Sakata, K. Kitamura, M. Morita, and T. Ishida Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck Head Neck 19 1997 611 616
64. K. Moin, L. Cao, N.A. Day, J.E. Koblinski, and B.F. Sloane Tumor cell membrane cathepsin B Biol. Chem. 379 1998 1093 1099
65. R. Dennhofer, P. Kurschat, P. Zigrino, A. Klose, A. Bosserhoff, and G. Van:Muijen Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases Int. J. Cancer 106 2003 316 323
66. D. Keppler, M.C. Fondaneche, V. Dalet-Fumeron, M. Pagano, and P. Burtin Immunohistochemical and biochemical study of a cathepsin B-like proteinase in human colonic cancers Cancer Res. 48 1988 6855 6862
67. A. Ulmer, V. Korber, H. Schmid, and G. Fierlbeck Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin Exp. Dermatol. 7 1998 14 17
68. L.G. Hazen, F.E. Bleeker, B. Lauritzen, S. Bahns, J. Song, and A. Jonker Comparative localization of cathepsin B protein and activity in colorectal cancer J. Histochem. Cytochem. 48 2000 1421 1430
69. D. Jean, M. Bar-Eli, S. Huang, K. Xie, F. Rodrigues-Lima, and J. Hermann A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma Cancer Res. 56 1996 254 258
70. T. Kageshita, A. Yoshii, T. Kimura, K. Maruo, T. Ono, and M. Himeno Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours Arch. Dermatol. Res. 287 1995 266 272
71. W.Q. Zheng, L.M. Looi, and P.L. Cheah Correlation between laminin and cathepsin D expressions in breast carcinoma Tumori 88 2002 296 299
72. K. Matsuo, I. Kobayashi, T. Tsukuba, T. Kiyoshima, Y. Ishibashi, and A. Miyoshi Immunohistochemical localization of cathepsins D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells Hum. Pathol. 27 1996 184 190
73. Y. Izumi, M. Hirata, H. Hasuwa, R. Iwamoto, T. Umata, and K. Miyado A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor EMBO J. 17 1998 7260 7272
74. R.A. Black, and J.M. White ADAMs: focus on the protease domain Curr. Opin. Cell Biol. 10 1998 654 659
75. M.J. Duffy, D.J. Lynn, A.T. Lloyd, and C.M. O'Shea The ADAMs family of proteins: from basic studies to potential clinical applications Thromb. Haemost. 89 2003 622 631
76. K. Horiuchi, G. Weskamp, L. Lum, H.P. Hammes, H. Cai, and T.A. Brodie Potential role for ADAM15 in pathological neovascularization in mice Mol. Cell. Biol. 23 2003 5614 5624
77. C. O'Shea, N. McKie, Y. Buggy, C. Duggan, A.D. Hill, and E. McDermott Expression of ADAM-9 mRNA and protein in human breast cancer Int. J. Cancer 105 2003 754 761
78. K. Iba, R. Albrechtsen, B.J. Gilpin, F. Loechel, and U.M. Wewer Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion Am. J. Pathol. 154 1999 1489 1501
79. R. Yavari, C. Adida, P. Bray-Ward, M. Brines, and T. Xu Human metalloprotease-disintegrin Kuzbanian regulates sympathoadrenal cell fate in development and neoplasia Hum. Mol. Genet. 7 1998 1161 1167
80. L.G. Jia, K. Shimokawa, J.B. Bjarnason, and J.W. Fox Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins Toxicon 34 1996 1269 1276
81. M.A. McLane, M.A. Kowalska, L. Silver, S.J. Shattil, and S. Niewiarowski Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets Biochem. J. 301 1994 429 436
82. L. Beviglia, G.J. Stewart, and S. Niewiarowski Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model Oncol. Res. 7 1995 7 20
83. C.L. Wilson, K.J. Heppner, P.A. Labosky, B.L. Hogan, and L.M. Matrisian Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin Proc. Natl. Acad. Sci. USA 94 1997 1402 1407
84. T. Itoh, M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res. 58 1998 1048 1051
85. R. Masson, O. Lefebvre, A. Noel, M.E. Fahime, M.P. Chenard, and C. Wendling In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy J. Cell Biol. 140 1998 1535 1541
86. V. Montel, J. Kleeman, D. Agarwal, D. Spinella, K. Kawai, and D. Tarin Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression Cancer Res. 64 2004 1687 1694
87. M. Balbin, A. Fueyo, A.M. Tester, A.M. Pendas, A.S. Pitiot, and A. Astudillo Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nat. Genet. 35 2003 252 257
88. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, and K. Tamaki Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat. Cell Biol. 2 2000 737 744
89. Y. Hamano, M. Zeisberg, H. Sugimoto, J.C. Lively, Y. Maeshima, and C. Yang Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin Cancer Cell 3 2003 589 601
90. L.M. Coussens, C.L. Tinkle, D. Hanahan, and Z. Werb MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
91. N. Rousselet, L. Mills, D. Jean, C. Tellez, M. Bar-Eli, and R. Frade Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment Cancer Res. 64 2004 146 151
92. E. Mazzoni, A. Adam, E. Bal:de:Kier:Joffe, and J.A. Aguirre-Ghiso Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo Mol. Cancer Res. 1 2003 776 787
93. A.K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori A causal role for E-cadherin in the transition from adenoma to carcinoma Nature 392 1998 190 193
94. L.E. Reynolds, L. Wyder, J.C. Lively, D. Taverna, S.D. Robinson, and X. Huang Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins Nat. Med. 8 2002 27 34
95. D. Taverna, H. Moher, D. Crowley, L. Borsig, A. Varki, and R.O. Hynes Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins Proc. Natl. Acad. Sci. USA 101 2004 763 768